Congress of the European Committee for Treatment and Research in Multiple Sclerosis
The Neurology Today Conference Reporter aims to keep neurologists up to date and fully informed about the most noteworthy news from major professional meetings.
Whether you are attending the meeting or reading about it remotely, you’ll be able to access daily, concise peer-reviewed reports from major neurology conferences via email blasts that are optimized for web and mobile viewing.
The Neurology Today Conference Reporter highlights only those papers and presentations deemed noteworthy by the Neurology Today editors. All reports are vetted and reviewed by our team of neurologist reviewers, as well. Each report includes commentary from independent experts and appears with additional perspectives in the print edition of Neurology Today.
Peer-reviewed by the Neurology Today Editors
From left to right: Editor-in-Chief Joseph E. Safdieh, MD, FAAN, the inaugural Louis and Rachel Rudin Foundation Education Scholar and associate professor and vice chairman of neurology for education at Weill Cornell Medicine; and Stephen Krieger, MD, FAAN, director of the Mount Sinai neurology residency program and a member of the editorial advisory board.
Hot off the press from the 2017 Congress of the European Committee for Treatment and Research in Multiple Sclerosis:
October 31–An Asthma Drug Reduces Brain Volume Loss in Progressive MS
October 31–Ozanimod Shows Efficacy in Relapsing-remitting MS
October 31–Is Natalizumab Safe During Pregnancy?
October 31–Why MOG Antibody Disease May or May Not Be Part of the Neuromyelitis Optica Spectrum
October 30–High Percentage of MS Patients Have Benign Course
October 30–MAGNIMS and McDonald Criteria Similar in Predicting Conversion to MS
October 30–Debate: Does Radiologically-Isolated Syndrome Require Treatment?
October 30–Siponimod Found to Slow Disability Progression in Progressive MS